Basel, Switzerland

Moise Azria

USPTO Granted Patents = 25 


 

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 248(Granted Patents)


Location History:

  • Paris, FR (1984 - 1988)
  • Basel, CH (1991 - 2017)

Company Filing History:


Years Active: 1984-2017

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Moise Azria: Innovator in Pharmaceutical Compositions

Introduction

Moise Azria, based in Basel, Switzerland, is an accomplished inventor with a remarkable portfolio of 25 patents to his name. His work primarily focuses on developing innovative pharmaceutical compositions aimed at improving drug delivery systems.

Latest Patents

Among his latest patents, Azria has made significant strides in oral pharmaceutical compositions. His invention provides a means to deliver drugs effectively through oral administration, particularly targeting poly (amino acids) such as peptides, peptidomimetics, and proteins. This innovative composition showcases rapid disintegration and/or dissolution, ensuring that the active ingredient can achieve the desired therapeutic effect.

Another noteworthy patent involves the use of 5-CNAC as an oral delivery agent for parathyroid hormone fragments. This invention presents pharmaceutical compositions that facilitate the effective oral delivery of parathyroid hormone (PTH) and outlines methods for administering these compositions. Furthermore, it includes approaches for stimulating new bone formation and treating or preventing osteoporosis.

Career Highlights

Throughout his career, Moise Azria has contributed to leading companies in the pharmaceutical industry, including Novartis AG and Sandoz GmbH. His work has had a profound impact on the field of drug delivery, enhancing therapeutic outcomes for patients.

Collaborations

Azria has collaborated with notable professionals in the industry, including Simon David Bateman and Joseph Ault. These partnerships have likely fostered an environment of innovation and knowledge sharing, facilitating the advancement of his groundbreaking pharmaceutical compositions.

Conclusion

Moise Azria's contributions to the realm of pharmaceuticals highlight his dedication to improving drug delivery mechanisms. With a strong portfolio of patents and a history of collaboration with key industry figures, Azria continues to be a prominent innovator in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…